Manufacturers Life Insurance Company, The V Tv Therapeutics Inc. Transaction History

Manufacturers Life Insurance Company, The

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$0.7 - $1.58 $830 - $1,873	-1,186 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$3.91 - $7.83 $5,861 - $11,737	-1,499 Reduced 55.83%	1,186 $5,000
Q4 2017 Feb 08, 2018	BUY	$3.9 - $7.77 $2,862 - $5,703	734 Added 37.62%	2,685 $16,000
Q3 2017 Nov 14, 2017	BUY	$3.83 - $6.07 $7,472 - $11,842	1,951	1,951 $12,000

243K

Ticker VTVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,483,600
Market Cap $1.42B
Description
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetran...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.